Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05178069 · ClinicalTrials.gov registry record · Phase 2

LGG Supplementation in Patients With AUD and ALD

A Phase 2 study of Alcohol Use Disorder and Alcohol-associated Liver Disease, sponsored by University of Louisville.

Recruiting
Registry status
Phase 2
Development phase
60
Enrollment target
1
Study location

NCT05178069 is a Phase 2 study of Alcohol Use Disorder and Alcohol-associated Liver Disease that is actively recruiting participants, run by University of Louisville. The registered enrollment target is 60 participants, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05178069, a Phase 2 study of Alcohol Use Disorder and Alcohol-associated Liver Disease, is actively recruiting participants, sponsored by University of Louisville.

RECRUITING
Registry status
Phase 2
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

To test the efficacy of 6-month LGG compared to placebo in treating Alcoholic Use Disorder (AUD) and liver injury in Alcoholic Hepatitis (AH). And to evaluate the effects of LGG treatment compared to placebo on therapeutic-mechanistic markers of the gut-brain axis and pro-inflammatory activity in patients with AUD and moderate AH

Conditions Studied

Alcohol Use Disorder Alcohol-associated Liver Disease

Interventions

  • DRUG : Placebo for Probiotic
  • DIETARY_SUPPLEMENT Lactobacillus Rhamnosus GG

Study Locations (1)

Kentucky

  • University of Louisville Hospital - Louisville

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2022-06-01
Est. Completion 2027-02-28
Phase Phase 2

Sponsor

University of Louisville

217 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05178069

The ClinicalTrials.gov registry entry for NCT05178069 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (82% lower). The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Alcohol Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which : Placebo for Probiotic is the first listed.

NCT05178069 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.

Frequently Asked Questions

What is clinical trial NCT05178069 about?

NCT05178069 is a clinical study titled "LGG Supplementation in Patients With AUD and ALD". To test the efficacy of 6-month LGG compared to placebo in treating Alcoholic Use Disorder (AUD) and liver injury in Alcoholic Hepatitis (AH). And to evaluate the effects of LGG treatment compared to placebo on therapeutic-mechanistic markers of the gut-brain axis and pro-inflammatory activity in pa...

What is the current status of trial NCT05178069?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2022-06-01. Estimated completion is 2027-02-28.

What conditions does trial NCT05178069 study?

This clinical trial studies the following conditions: Alcohol Use Disorder, Alcohol-associated Liver Disease.

What interventions are being tested in trial NCT05178069?

The interventions under investigation include: : Placebo for Probiotic (DRUG), Lactobacillus Rhamnosus GG (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05178069?

This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05178069 being conducted?

This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Alcohol Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Alcohol Use Disorder

All registered trials for this condition

Alcohol-associated Liver Disease

All registered trials for this condition

Kentucky

All trials with a study site in Kentucky

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.